AVL.TO Stock Quote & Alerts

AVL.TOAVL.TO

No data available

Want to monitor AVL.TO?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

No company information available

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

Key Statistics

About

News

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Freeport-McMoran

What Investors Should Know About a $186K OneStream Insider Stock Sale

FRMI INVESTOR NOTICE: Fermi Inc. Investors with Substantial Losses Have Opportunity to Lead the Fermi Class Action Lawsuit

Google teams up with Walmart and other retailers to enable shopping within Gemini AI chatbot

Is the Schwab U.S. Dividend Equity ETF a Buy Now?

SoFi: Illogical Analyst Hate

Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout from the EMPEROR Study of Zorevunersen for the Treatment of Dravet Syndrome

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Firefly Aerospace

Should You Forget AGNC Investment and Buy Realty Income Instead?

Dutch Bros: Could This Fast-Growing Coffee Chain Be a Long-Term Winner?​

3 AI Stocks Poised for Explosive Growth as Enterprise Spending Accelerates in 2026

Alphatec Stock Up 126% as CEO Sells $2 Million in Shares -- Here's What Investors Should Know

3 U.S. Oil Stocks That Could Benefit From President Donald Trump's Actions in Venezuela

SLM INVESTOR DEADLINE: SLM Corporation a/k/a Sallie Mae Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SKYE Deadline: SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit

Xometry Shares Beat the S&P 500 as Insider Sells $1.7 Million

VNQI vs. REET: How Does Vanguard's Fund Compare Against the Largest Global Real Estate ETF?

Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference

Rush Street Interactive CEO Sells $3 Million as Stock Gains 38% in 12 Months

What Investors Should Know About a $1.5 Million Apogee Insider Sale Amid a 60% Stock Rally